Repository logo
 
Publication

Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal)

2008Journal article Open access
Simple item page
dc.contributor.authorFreitas, Ana I.
dc.contributor.authorMendonça, Isabel
dc.contributor.authorGuerra, Graça
dc.contributor.authorBrión, Maria
dc.contributor.authorReis, Roberto P.
dc.contributor.authorCarracedo, Angel
dc.contributor.authorBrehm, António
dc.date.accessioned2020-11-16T12:03:34Z
dc.date.available2020-11-16T12:03:34Z
dc.date.issued2008
dc.description.abstractElevated levels of plasma homocysteine, an independent risk factor and a strong predictor of mortality in patients with coronary artery disease (CAD), can result from nutritional deficiencies or genetic errors, including methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms. The contribution of these polymorphisms in the development of CAD remains controversial. We analysed the impact of MTHFR C677T and A1298C on fasting homocysteine and CAD in 298 CAD patients proved by angiography and 510 control subjects from the Island of Madeira (Portugal). After adjustment for other risk factors, plasma homocysteine remained independently correlated with CAD. Serum homocysteine was significantly higher in individuals with 677TT and 1298AA genotypes. There was no difference in the distribution of MTHFR677 genotypes between cases and controls but a significant increase in 1298AA prevalence was found in CAD patients. In spite of the clear effect of C677T mutation on elevated homocysteine levels we only found an association between 1298AA genotype and CAD in this population. The simultaneous presence of 677CT and 1298AA genotypes provides a significant risk of developing the disease, while the 1298AC genotype, combined with 677CC, shows a significant trend towards a decrease in CAD occurrence. The data shows an independent association between elevated levels of homocysteine and CAD. Both MTHFR polymorphisms are associated with increased fasting homocysteine (677TT and 1298AA genotypes), but only the 1298AA variant shows an increased prevalence in CAD group. Odds ratio seem to indicate that individuals with the MTHFR 1298AA genotype and the 677CT/1298AA compound genotype had a 1.6-fold increased risk for developing CAD suggesting a possible association of MTHFR polymorphisms with the risk of CAD in Madeira population.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationFreitas, A. I., Mendonça, I., Guerra, G., Brión, M., Reis, R. P., Carracedo, A., & Brehm, A. (2008). Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal). Thrombosis research, 122(5), 648-656.pt_PT
dc.identifier.doi10.1016/j.thromres.2008.02.005pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.13/2983
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherEuropean Thrombosis Research Organisationpt_PT
dc.relationGenetic polymorphisms and risk of coronary heart disease in Madeira. Interaction with cardiovascular risk markers and their role in prognosis.
dc.relationPOLIMORFISMOS GENÉTICOS E RISCO DE DOENÇA CORONÁRIA NA MADEIRA. INTERACÇÃO COM OS MARCADORES DE RISCO CARDIOVASCULAR E O SEU PAPEL NO PROGNÓSTICO
dc.subjectHomocysteinept_PT
dc.subjectGene polymorphismspt_PT
dc.subjectCoronary artery diseasept_PT
dc.subjectMadeira (Portugal)pt_PT
dc.subject.pt_PT
dc.subjectFaculdade de Ciências da Vidapt_PT
dc.titleMethylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal)pt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardTitleGenetic polymorphisms and risk of coronary heart disease in Madeira. Interaction with cardiovascular risk markers and their role in prognosis.
oaire.awardTitlePOLIMORFISMOS GENÉTICOS E RISCO DE DOENÇA CORONÁRIA NA MADEIRA. INTERACÇÃO COM OS MARCADORES DE RISCO CARDIOVASCULAR E O SEU PAPEL NO PROGNÓSTICO
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/POCI/POCTI%2FMGI%2F38697%2F2001/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/POCI-2010/SFRH%2FBD%2F8592%2F2002/PT
oaire.citation.endPage656pt_PT
oaire.citation.startPage648pt_PT
oaire.citation.titleThrombosis Researchpt_PT
oaire.citation.volume122(5)pt_PT
oaire.fundingStreamPOCI
oaire.fundingStreamPOCI-2010
person.familyNameCamacho de Freitas
person.familyNamePalma dos Reis
person.familyNameBrehm
person.givenNameAna Isabel
person.givenNameRoberto José
person.givenNameAntonio
person.identifier.ciencia-id0E17-FBDF-CE9D
person.identifier.ciencia-idE915-4E29-A5FA
person.identifier.ciencia-id3613-8D1F-0EDF
person.identifier.orcid0000-0003-3168-5340
person.identifier.scopus-author-idAuthor ID 7006085833
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication5da59ca2-ff33-45cb-9b32-88459d8ca726
relation.isAuthorOfPublication5c115130-eb5e-4d69-a0fb-096a1260410a
relation.isAuthorOfPublication62d279e2-247a-4652-a370-3e8c2a846e31
relation.isAuthorOfPublication.latestForDiscovery62d279e2-247a-4652-a370-3e8c2a846e31
relation.isProjectOfPublication843a5004-d4da-4fe6-beac-48a821160b10
relation.isProjectOfPublication2746fd93-4d7b-42f8-bdf9-8d0def0e42e5
relation.isProjectOfPublication.latestForDiscovery2746fd93-4d7b-42f8-bdf9-8d0def0e42e5

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery diseaseBrehm.pdf
Size:
154.69 KB
Format:
Adobe Portable Document Format
Download

Collections

Artigos em revistas internacionais